IQVIA Holdings Inc. (NYSE:IQV) recently gained the attention of First Affirmative Financial Network, as the firm purchased a new stake in the company during the second quarter of this fiscal year. According to their recent 13F filing with the Securities & Exchange Commission, First Affirmative Financial Network acquired 931 shares of IQVIA’s stock, which were valued at approximately $209,000.
IQVIA, known for its provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry, operates in various regions including the Americas, Europe, Africa, and the Asia-Pacific. The company is divided into three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
The most recent quarterly earnings report released by IQVIA on August 1st showcased positive results. The medical research company reported an impressive earnings per share (EPS) of $2.22 for the quarter. This exceeded analysts’ consensus estimates of $2.09 by $0.13. Additionally, IQVIA generated revenue of $3.73 billion during this period, surpassing analyst estimates of $3.70 billion.
Notably, IQVIA demonstrated a return on equity of 30.14% and a net margin of 7.47%. These metrics highlight the company’s ability to efficiently utilize its resources while maintaining profitability.
Looking ahead to the remainder of this fiscal year, equities analysts predict that IQVIA Holdings Inc. will post an EPS of 9.24 for the current fiscal year.
The investment made by First Affirmative Financial Network indicates their confidence in IQVIA’s potential for growth within the life sciences industry. With its diverse range of services and strategic presence in major global markets, IQVIA remains well-positioned for continued success in delivering valuable solutions to its clients.
Disclaimer: The views expressed in this article are solely those of the author and do not represent the official position of IQVIA Holdings Inc. or any other affiliated parties. This article is for informational purposes only and should not be taken as investment advice.
&Institutional Investors Show Confidence in IQVIA with Notable Stake Changes
September 17, 2023 – Institutional investors have recently made notable changes to their positions in IQVIA Holdings Inc. Old North State Trust LLC saw a tremendous increase of 342.2% in its stake during the 1st quarter, now owning 597 shares valued at $27,000 after purchasing an additional 462 shares. Similarly, Hanson & Doremus Investment Management increased its holdings by 300.0% during the same period and now owns 144 shares worth $29,000 after acquiring an additional 108 shares.
AllSquare Wealth Management LLC entered the picture as well, buying a new stake in IQVIA worth approximately $36,000 in the first quarter. Live Oak Investment Partners also acquired a new position in IQVIA valued at around $41,000 during the fourth quarter of last year. Lastly, Headlands Technologies LLC grew its position by 62.3% in the first quarter and now possesses 224 shares worth $45,000 after adding an extra 86 shares to its portfolio.
It is important to note that institutional investors currently own a staggering 86.82% of IQVIA’s stock, which further emphasizes their confidence and belief in the company’s prospects.
On Friday, September 17th, IQV opened at a price of $211.71. The company boasts a quick ratio and current ratio of both standing at 0.81 while exhibiting a debt-to-equity ratio of 2.16. With regards to market capitalization, it amounts to an impressive $38.77 billion.
The firm maintains attractive financial ratios with a PE ratio of 36.44 and a P/E/G ratio of just above two at exactly 2.15. IQVIA has managed to maintain stable growth even amid market volatility thanks to its beta value standing steady at 1.37.
When examining the company’s recent performance trends from moving averages, IQVIA Holdings Inc. has a fifty-day simple moving average of $220.12 and a two hundred-day simple moving average of $208.10.
The stock’s performance over the past year has observed a range with a low of $165.75 and a high of $241.86.
Various brokerage firms have recently released reports on IQVIA, providing insights into its current standing in the market. Citigroup increased its price target from $200.00 to $225.00 while maintaining a “neutral” rating for the stock in an August 2nd research report.
Barclays also raised its price target from $230.00 to $250.00 back on June 27th. StockNews.com initiated coverage on IQVIA and issued a “hold” rating for the company in an August 17th report.
Furthermore, Morgan Stanley upgraded their target price from $220.00 to $240.00 and expressed an “overweight” rating for the stock in a research note published on August 2nd.
Stifel Nicolaus was among those with bullish sentiments, increasing their price target from $255.00 to an impressive $281.00 while reiterating a “buy” rating on August 2nd.
Overall, analysts seem fairly optimistic about IQVIA’s future prospects, as evidenced by their average rating of “Moderate Buy.” The consensus price target stands at $252.00 according to Bloomberg.com.
For investors seeking further information and analysis regarding IQVIA’s recent developments and outlook, it is advised to consult our latest report on the company.
&Other Institutional Investors Make Changes to Their Positions in IQVIA
Website: [Insert Website Link]
Date Published: September 17, 2023